Da. Fisher et al., The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism, J CLIN END, 85(8), 2000, pp. 2722-2727
Measurements of serum concentrations of free T-4, T-3, TSH, and thyroglobul
in (Tg) were conducted in 42 infants (2-9 months of age) detected and treat
ed through the Northwest Newborn Regional Screening Program and 63 children
and adolescents (1-18 yr of age) with congenital hypothyroidism (CH) detec
ted and managed in the Northern California Kaiser Permanente Medical Care P
rogram. Normal feedback control axis data were developed by Quest Diagnosti
cs, Inc. - Nichols Institute Diagnostics and Loma Linda University, from fr
ee T-4 and TSH measurements in 589 healthy subjects, 2 months to 54 yr of a
ge; 83 untreated hypothyroid patients; and 116 untreated hype-thyroid patie
nts. Twenty-four of the 42 CH infants and 57 of the 63 CH children manifest
ed serum TSH concentrations appropriate for the measured free T-4 level. In
the remaining 18 infants and 6 children, serum free T-4 values were increa
sed 0.2-1.4 ng/dL (2.6-18.0 pmol/L) for the prevailing TSH level, suggestin
g a state of mild to moderate pituitary-thyroid hormone resistance. In the
treated children, the mean T-3 concentration was lower (by 32%, 102 vs. 150
ng/dL; 1.57 vs. 2.31 nmol/L) than in normal children, in agreement with ea
rlier data in hypothyroid adults treated with exogenous T-4. Serum Tg conce
ntrations were normal or elevated in 90% of the 19 children with ectopic gl
ands and 93% of 27 children with eutopic glands in whom measurements were a
vailable. There was a positive correlation between serum TSH and Tg concent
rations (P < 0.001), suggesting significant endogenous thyroid hormone prod
uction in these children. Our results suggest that the majority of infants
and children with CH have a normal hypothalamic-pituitary-thyroid negative
feedback control axis during treatment and that the measurement of serum TS
H is a useful marker complementing the free T-4 measurement in the manageme
nt of children with CH. A minority have variable pituitary-thyroid hormone
resistance, with relatively elevated serum TSH levels for their prevailing
serum free T-4 concentration. The prevalence of resistance is greater (43%)
in young infants (<1 yr of age) than in older children (10%), indicating t
hat, in most children, the resistance improves with age.